Clinical trial
Pharmacogenetics of Response to GLP1R Agonists
NCT05071898 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetics of Response to GLP1R Agonists
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 11, 2022
- Completion date
- April 30, 2028
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes type 2, obesity